Controlled release of levamisole from poly-(ε-caprolactone) matrices II. Effects of water-soluble polymer and iron powder incorporated into the matrices
- 1 April 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 132 (1-2) , 153-163
- https://doi.org/10.1016/0378-5173(95)04346-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Physico-mechanical properties of poly(ε-caprolactone) for the construction of rumino-reticulum devices for grazing animalsBiomaterials, 1995
- Quantitation of levamisole in plasma using high performance liquid chromatographyEuropean Journal of Drug Metabolism and Pharmacokinetics, 1995
- Controlled drug release from implantable matrices based on hydrophobia polymersBiomaterials, 1992
- Base-induced polymer hydrolysis in poly(β-hydroxybutyrate/β-hydroxyvalerate) matricesJournal of Controlled Release, 1991
- Controlled sustained delivery of monensin in cattle: The monensin R.D.D.®Journal of Controlled Release, 1989
- The morantel sustained release trilaminate: A device for the controlled ruminal delivery of morantel to cattleJournal of Controlled Release, 1988
- Oral Controlled-Release Delivery of Ivermectin in Cattle via an Osmotic PumpJournal of Pharmaceutical Sciences, 1985
- Therapeutic and prophylactic efficacy of morantel when administered directly into the rumen of cattle on a continuous basisVeterinary Parasitology, 1983
- Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (ε-caprolactone), and their copolymers in vivoBiomaterials, 1981
- Rate of Release of Medicaments from Ointment Bases Containing Drugs in SuspensionJournal of Pharmaceutical Sciences, 1961